SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matrix Pharmaceutical (MATX) -- Ignore unavailable to you. Want to Upgrade?

To: MOLLYSUE who wrote (178)3/11/1998 10:31:00 PM
From: Peter Singleton  Read Replies (1) | Respond to of 240
 
Folks,

I don't follow MATX since I took my shares out and shot them for a loss last year ... but I think the data at the Dermatologist meeting was definitely MATX's, but the results were announced some time ago ... so it wasn't new news.

Peter



To: MOLLYSUE who wrote (178)3/25/1998 2:43:00 PM
From: biowa  Read Replies (1) | Respond to of 240
 
MollySue,

Yes, I also believe that data was MATX, but nothing new. Did you see on CNN today about some doc's putting chemo agents in a viscous carrier and injecting it into oral tumors? Usual media hype about the wonderful potential... all I could think of was, "so why can't MATX get this to market?"

biowa


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News